Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 26, 2022Frontiers in OncologyOpen Access

A Phase I Trial to Determine the Safety and Tolerability of Autophagy Inhibition Using Chloroquine or Hydroxychloroquine in Combination With Carboplatin and Gemcitabine in Patients With Advanced Solid Tumors

View Full Paper
Ask AI
Bookmark
Share

Authors

NKNagla Abdel KarimInova Fairfax HospitalAUAsad UllahTexas Tech University Health Sciences CenterIAImran AhmadUniversity of Illinois Urbana-Champaign

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Karim et al. (2022) studied this question.

synapsesocial.com/papers/6aab607f4499d5c0d737b99ehttps://doi.org/10.3389/fonc.2022.811411
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer2019 · 302 citations
  2. 2Inhibition of autophagy with bafilomycin and chloroquine decreases mitochondrial quality and bioenergetic function in primary neurons2016 · 260 citations
  3. 3Targeting Autophagy in Cancer: Update on Clinical Trials and Novel Inhibitors2017 · 374 citations